|

Nimotuzumab Injection Clinical Trials

1 actively recruiting trial

Also known as: Nimotuzumab

Pipeline

Phase 2: 1

Top Sponsors

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1

Indications

  • Head Neck Cancer1
  • Head and Neck Squamous Cell Carcinoma (HNSCC)1
  • Head and Neck Squamous Cell Carcinoma1
  • Neoadjuvant Therapy1
  • Cancer1

Other1 trial

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.